Vaxcyte, Inc. (PCVX) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq set to open higher as AI stocks rebound ahead of earnings rush
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts PCVX Hot Sheet
Join SI Premium – FREE
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q1 EPS of ($1.04), in-line with the analyst estimate of ($1.04).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Reiterates Hold Rating on Meta Platforms Inc. (META) Ahead of Q3 Earnings
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- StoneX Reiterates Buy Rating on Galaxy Digital (GLXY)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
